CEO: Raul R. Rodriguez
Employees: 162
IPO: Nov 29, 2000
Prijs
€ 27,50
Verandering
▲ € 0,46
1,70%
Marktkapitalisatie
508,01M
Dagbereik
€ 27,35
€ 28,23
52-Weeksbereik
€ 15,50
€ 52,24
Volume
239.451
50D / 200D Gem.
€ 31,80
€ 32,98
Vorige Slotkoers
€ 27,04
Quick Summary
Belangrijkste Punten
Revenue grew 18,50% annually over 5 years — strong growth
Earnings grew 1999,08% over the past year
ROE of 185,94% indicates high profitability
Net margin of 124,72% shows strong profitability
Debt/Equity of 0,14 — conservative balance sheet
Generating 75,66M in free cash flow
Groei
Revenue Growth (5Y)
18,50%
Boven sectorgemiddelde (9,60%)
Revenue (1Y)64,15%
Earnings (1Y)1999,08%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
185,94%
Boven sectorgemiddelde (3,61%)
ROIC21,16%
Net Margin124,72%
Op. Margin42,63%
Veiligheid
Debt / Equity
0,14
Onder sectorgemiddelde (0,23)
Current Ratio2,42
Interest Coverage17,14
Waardering
P/E Ratio
1,38
Boven sectorgemiddelde (0,23)
Forward P/EN/A
P/B Ratio1,30
EV/EBITDA4,15
Dividend Yield0,00%
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (638 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,4 | 0,2 |
| P/B | 1,3 | 2,9 |
| ROE % | 185,9 | 3,6 |
| Net Margin % | 124,7 | 3,9 |
| Rev Growth 5Y % | 18,5 | 9,6 |
| D/E | 0,1 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 64,15% | Revenue Growth (3Y) | 58,67% |
| Earnings Growth (1Y) | 1999,08% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18,50% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 294,28M | Net Income (TTM) | 367,02M |
| ROE | 185,94% | ROA | 71,46% |
| Gross Margin | 93,33% | Operating Margin | 42,63% |
| Net Margin | 124,72% | Free Cash Flow (TTM) | 75,66M |
| ROIC | 21,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 2,42 |
| Interest Coverage | 17,14 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 1,38 | Forward P/E | N/A |
| P/B Ratio | 1,30 | P/S Ratio | 1,73 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | 4,15 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 14,89% | ||
| Market Cap | 508,01M | Enterprise Value | 520,73M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 294,28M | 179,28M | 116,88M | 120,24M | 149,24M |
| Net Income | 367,02M | 17,49M | -25,09M | -58,57M | -17,91M |
| EPS (Diluted) | 19,48 | 0,99 | -1,44 | -3,40 | -1,10 |
| Gross Profit | 274,66M | 160,63M | 109,77M | 118,49M | 148,15M |
| Operating Income | 125,47M | 24,19M | -20,49M | -55,55M | -12,50M |
| EBITDA | 127,88M | 28,51M | -16,98M | -53,87M | -11,29M |
| R&D Expenses | 33,30M | 23,38M | 24,52M | 60,27M | 65,24M |
| SG&A Expenses | 115,90M | 113,06M | 105,74M | 112,45M | 91,89M |
| D&A | 2,42M | 2,23M | 1,24M | 998.000,0 | 1,16M |
| Interest Expense | 7,32M | 7,92M | 6,87M | 3,71M | 4,86M |
| Income Tax | -245,20M | 881.000,0 | 0,0 | 0,0 | 605.000,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 513,59M | 163,98M | 117,23M | 134,28M | 167,33M |
| Total Liabilities | 122,11M | 160,69M | 145,87M | 147,90M | 136,95M |
| Shareholders' Equity | 391,48M | 3,29M | -28,64M | -13,62M | 30,37M |
| Total Debt | 53,30M | 59,97M | 60,58M | 41,55M | 30,57M |
| Cash & Equivalents | 40,58M | 56,75M | 32,79M | 24,46M | 18,89M |
| Current Assets | 240,17M | 135,10M | 99,27M | 115,90M | 154,47M |
| Current Liabilities | 99,24M | 63,30M | 53,27M | 65,21M | 63,55M |
Strategiescores
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#6 of 223
#14 of 153
#62 of 200
Custom
Full Throttle
#113 of 141
Custom
Lower Risk
#22 of 136
Recente Activiteit
Ingestapt
Capital Light Compounder
Apr 2, 2026
Ingestapt
Growth Investing (Philip Fisher)
Apr 2, 2026
Ingestapt
Value Investing (Warren Buffett)
Apr 2, 2026
Ingestapt
Full Throttle
Apr 2, 2026
Ingestapt
Lower Risk
Apr 2, 2026